Ossio

OSSIO is a pioneering company in the orthopedic fixation market, focusing on biointegrative implants that encourage natural bone healing. Headquartered in Caesarea, Israel, with commercial operations in Boston, Massachusetts, OSSIO aims to set the gold standard in orthopedic fixation by eliminating the need for hardware removal procedures, reducing implant-related complications, and improving overall healthcare economics in orthopedics. The company's proprietary implant material combines the strength necessary for functional fixation with the ability to fully integrate into the native anatomy without causing adverse inflammation. This innovative technology allows surgeons to offer secure, all-natural bone repair solutions that patients prefer. OSSIO serves a wide range of clients, including orthopedic surgeons, healthcare providers, and payors, operating primarily in the medical device and healthcare sectors. The business model revolves around the sale of its unique implants and disposable, sterile instruments, leveraging existing reimbursement and surgical techniques to facilitate adoption. Revenue is generated through the direct sale of these products to healthcare institutions and providers.

Keywords: orthopedic fixation, biointegrative implants, bone healing, healthcare economics, medical devices, natural bone repair, surgical applications, implant material, healthcare providers, orthopedic surgeons.